Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis

[1] Loveday DT(2012)The rheumatoid foot and ankle: current evidence Foot Ankle Surg 18 94-102

[2] Jackson GE(2016)Preventive treatments for rheumatoid arthritis: issues regarding patient preferences Curr Rheumatol Rep 18 51-1

[3] Geary NP(2015)Erosive pustular dermatosis of the scalp arising concomitantly with elevation of serum matrix metalloproteinase-3 in a patient with rheumatoid arthritis J Dermatol 42 540-14

[4] Finckh A(2013)The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis Rheumatol Int 33 2309-126

[5] Escher M(2012)Baseline serum MMP-3 levels in patients with rheumatoid arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up Arthritis Res Ther 14 R30-42

[6] Liang MH(2005)MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1 Arthritis Res Ther 7 R118-10

[7] Bansback N(2014)Contributions of ultrasound beyond clinical data in assessing inflammatory disease activity in rheumatoid arthritis: current insights and future prospects Rheumatology 53 2136-201

[8] Aoshima M(2015)Role of ultrasound in assessing remission in rheumatoid arthritis Diagn Interv Imaging 96 3-23

[9] Ito T(2009)Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project Arthritis Rheum 61 1194-9

[10] Tokura Y(2011)Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis Arthritis Res Ther 13 R78-9

[1] Loveday DT(2012)The rheumatoid foot and ankle: current evidence Foot Ankle Surg 18 94-102

[2] Jackson GE(2016)Preventive treatments for rheumatoid arthritis: issues regarding patient preferences Curr Rheumatol Rep 18 51-1

[3] Geary NP(2015)Erosive pustular dermatosis of the scalp arising concomitantly with elevation of serum matrix metalloproteinase-3 in a patient with rheumatoid arthritis J Dermatol 42 540-14

[4] Finckh A(2013)The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis Rheumatol Int 33 2309-126

[5] Escher M(2012)Baseline serum MMP-3 levels in patients with rheumatoid arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up Arthritis Res Ther 14 R30-42

[6] Liang MH(2005)MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1 Arthritis Res Ther 7 R118-10

[7] Bansback N(2014)Contributions of ultrasound beyond clinical data in assessing inflammatory disease activity in rheumatoid arthritis: current insights and future prospects Rheumatology 53 2136-201

[8] Aoshima M(2015)Role of ultrasound in assessing remission in rheumatoid arthritis Diagn Interv Imaging 96 3-23

[9] Ito T(2009)Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project Arthritis Rheum 61 1194-9

[10] Tokura Y(2011)Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis Arthritis Res Ther 13 R78-9